{"id":"tp-50869","type":"article-newspaper","title":"aTyr Pharma Posts $7.43 Q3 GAAP Loss Per Share, Expects Resources to Fund Operations Into Late 2028","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/50869","datePublished":"2026-11-07T14:20:20.000Z","dateModified":"2026-11-07T14:20:20.000Z","language":"en","abstract":"aTyr held $50.3 million in cash, cash equivalents, restricted cash and available-for-sale investments at Sept. 30.","section":"Business","references":[]}